Sam Klempner, MD, Talks ctDNA for Nonmetastatic Gastric and Esophageal Cancers
Sam Klempner, MD, spoke about clinical management and ctDNA for gastrointestinal cancers.
Sam Klempner, MD, Discusses Minimal Residual Disease in Gastrointestinal Cancers
Sam Klempner, MD, spoke about the importance of expanding minimal residual disease platforms for patients with gastrointestinal cancers.
Sam Klempner, MD, Reviews ctDNA Role in Gastroesophageal Cancers
Sam Klempner, MD, spoke about utilizing ctDNA the treat nonmetastatic gastroesophageal cancers at 2022 IGCC.
Yelena Y. Janjigian, MD, Reviews MSI as a Biomarker in for Localized Gastric Cancer
Yelena Y. Janjigian, MD, spoke about which biomarkers were most predictive for treatment of localized gastric cancer.
Yelena Y. Janjigian, MD, Considers Immunotherapy Treatment Options for Gastric Cancer
Yelena Y. Janjigian, MD, spoke about using immunotherapy across settings to treat localized gastric cancer.
Laparoscopy Lead to Better OS, Noninferior RFS Vs Open Gastrectomy in Advanced Gastric Cancer
Laparoscopy compared with open gastrectomy was found to produce better overall survival outcomes at the 5-year follow-up analysis for patients with advanced gastric cancer.
TILs in Invasive Tumor Margins May Hold a Key to Gastric Cancer Prognosis
An analysis presented at 2022 IGCC showed that the level of CD8 + cells in the outer margin of gastric cancer tumors was significantly associated with survival outcomes and could inform prognosis.
Data Show Men With MSI-High Gastric Cancer Have Worse Survival Vs Female Counterparts
Men with MSI-high gastric cancer may have shorter overall survival than women, regardless of treatment modality.
Kohei Shitara, MD, Discusses Immunotherapy in Gastric Cancer at 2022 IGCC
Kohie Shitara, MD, spoke about the use of immunotherapy in the first-line setting for metastatic gastric cancer.
Low FAM46C Predictive of Inferior Survival Following Curative Resection for Gastric Adenocarcinoma
Post-resection survival could be predicted by FAM46C expression in patients with gastric adenocarcinoma.
Investigators Pool Data to Better Classify Prognosis in Gastric Tumor
In a presentation at 2022 IGCC, Ju-Seog Lee, PhD, discussed an analysis that combined tumor classification models to derive new prognostic subgroups in gastric cancer.
Benefit Seen With Laparoscopic Proximal Gastrectomy For Upper Third Early Gastric Cancer
Laparoscopic proximal gastrectomy led to less vitamin B12 supplement use than total gastrectomy without negatively impacting survival for upper third early gastric cancer.
Yelena Y. Janjigian, MD, Discusses Immunotherapy for Gastric Cancer
Yelena Y. Janjigian, MD, spoke about using immunotherapy to treat localized gastric cancer.
2 Commerce Drive Cranbury, NJ 08512